Joan Lo to Osteoporosis
This is a "connection" page, showing publications Joan Lo has written about Osteoporosis.
Connection Strength
5.220
-
Challenges of fracture risk assessment in Asian and Black women. Am J Manag Care. 2024 Mar; 30(3):140-144.
Score: 0.880
-
Osteoporosis and Fracture Risk among Older US Asian Adults. Curr Osteoporos Rep. 2023 10; 21(5):592-608.
Score: 0.846
-
The Epidemiology of Metatarsal Fractures Among Older Females With Bisphosphonate Exposure. J Foot Ankle Surg. 2020 Mar - Apr; 59(2):269-273.
Score: 0.667
-
Vitamin D Status Among Older Women Initiating Osteoporosis Therapy. J Am Geriatr Soc. 2019 10; 67(10):2207-2208.
Score: 0.643
-
Changes in bone mineral density in women with breast cancer receiving aromatase inhibitor therapy. Breast Cancer Res Treat. 2018 Apr; 168(2):523-530.
Score: 0.572
-
Applying ethnic-specific bone mineral density T-scores to Chinese women in the USA. Osteoporos Int. 2016 12; 27(12):3477-3484.
Score: 0.520
-
Oral health considerations in older women receiving oral bisphosphonate therapy. J Am Geriatr Soc. 2011 May; 59(5):916-22.
Score: 0.362
-
How Should We Counsel Asian Americans about Fracture Risk? J Am Geriatr Soc. 2020 07; 68(7):1613-1614.
Score: 0.169
-
Determinants of Oral Bisphosphonate Use Beyond 5 Years. J Manag Care Spec Pharm. 2020 Feb; 26(2):197-202.
Score: 0.166
-
Using Pharmacy Data and Adherence to Define Long-Term Bisphosphonate Exposure in Women. J Manag Care Spec Pharm. 2019 Jun; 25(6):719-723.
Score: 0.158
-
Bone health history in breast cancer patients on aromatase inhibitors. PLoS One. 2014; 9(10):e111477.
Score: 0.115
-
Bisphosphonate-related osteonecrosis of the jaw in patients with oral bisphosphonate exposure: clinical course and outcomes. J Oral Maxillofac Surg. 2012 Aug; 70(8):1844-53.
Score: 0.097
-
Application of new method for evaluating performance of fracture risk tool. Am J Manag Care. 2012 Oct 01; 18(10):e398.
Score: 0.025